CIK 0001055726
- Non-accelerated filer
- Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330969592
- Phone
- +1 858-410-3134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- 4 Open-market sale Director sold 3,045 shares at $6.62 ($20,158)
- 4 Option exercise Director acquired 8,700 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale CFO sold 10,000 shares at $8.52 ($85,200)
- 4 Open-market sale Director sold 26,583 shares at an average $8.57 ($227,694)
- 4 Open-market sale Director sold 2,000 shares at $8.75 ($17,500)
- 4 Open-market sale Chief Operating Officer sold 4,710 shares at $8.97 ($42,249)
- 4 Option exercise Director acquired 4,274 shares (option exercise)
- 4 Open-market sale Director sold 2,000 shares at $10.41 ($20,820)
- 4 Shares withheld for taxes CFO gave up 31,410 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 25,967 shares (to pay taxes)
- 4 Option exercise Director acquired 11,667 shares (option exercise)
- 4 Shares withheld for taxes Chief Executive Officer gave up 74,545 shares (to pay taxes)
- 4 Open-market sale Chief Operating Officer sold 16,881 shares at $10.06 ($169,823)
- 4 Shares withheld for taxes Chief Executive Officer gave up 98,297 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 16,514 shares (to pay taxes)
- 4 Open-market sale Director sold 7,000 shares at an average $9.39 ($65,736)
- 4 Shares withheld for taxes CFO gave up 25,862 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
Page 8 of 30 · 592 filings